Production strategies

Production Methods: AAROGYAM uses biomanufacturing to enable the cost-effective generation of Anti-CTLA-4. Key methods include: Cell Culture and Fermentation: Using genetically engineered cell lines to produce Anti-CTLA-4 proteins. Purification & Chromatography – Pure Extraction by Column Chromatography and ultra filtration. Sterile Filtration & Aseptic Processing – Preserving biological efficacy for therapeutic use.

Quality Testing Approaches For safety, efficacy and regulatory purposes AAROGYAM implements stringent Quality Assurance (QA) and Quality Control (QC) measures: Batch Control & Stability Testing – Ensuring uniformity and long-term stability of Anti-CTLA-4 formulations. Fluorescence-Based Assays - measurement of binding capability and molecular interactions. Regulatory Compliance & Risk Management – Compliance settings to align with pharmaceutical quality ICH guidelines.

Laboratory Plan AAROGYAM's biotech research laboratory Designed for efficiency and safety, ease of use, and scale: Cell Culture, Purification, Analytical Testing Dedicated Zones -Independent zones for cell culture, purification, and analytical Testing. Sophisticated Apparatuses – Devices such as bioreactors, chromatography systems, and fluorescence analyzers. Safety & Compliance – Biosafety protocols, Waste management and adherence to regulations